Equillium, Inc. (SWB:0FY) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jason Keyes Other companies: BlossomHill Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 6, 2026); Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024); Sesen Bio Inc (Director · May 3, 2021 – Jun 22, 2022 · Past) | Chief Financial Officer · Dec 10, 2020 – Feb 14, 2025 · Past |
| Martha Demski Other companies: Alpha Teknova, Inc. (Board Member · Since at least Aug 31, 2023); ADMA Biologics Inc (Director · Mar 6, 2023 – Mar 6, 2023 · Past); Chimerix Inc (Director · May 17, 2022 – Apr 21, 2025 · Past) | Director · Since at least May 24, 2022 |
| Krishna R Polu Other companies: Frazier Lifesciences Acquisition Corp (Director · Dec 8, 2020 – Nov 22, 2022 · Past) | Chief Medical Officer · Oct 11, 2018 – Apr 22, 2020 · Past |
| Mark Pruzanski Other companies: Intercept Pharmaceuticals Inc (Director · Apr 9, 2013 – Nov 8, 2023 · Past) | Director · Since at least Oct 11, 2018 |
| Barbara Troupin | Director · Since at least Feb 24, 2022 |
| Bruce Steel | Chief Executive Officer · Since at least Oct 26, 2026 |
| Christine Zedelmayer | Chief Operating Officer · Since at least May 27, 2026 |
| Daniel Bradbury | Chairman of the Board · Since at least Nov 5, 2026 |
| Penny Tom | SVP Finance and Principal Accounting Officer · Since at least Mar 6, 2024 |
| Snehal Naik | Chief Development Officer · Since at least May 13, 2026 |
| Stephen Connelly | President and Chief Scientific Officer · Since at least Jun 5, 2026 |